Exploring treatment-driven subclonal evolution of prognostic triple biomarkers: Dual gene fusions and chimeric RNA variants in novel subtypes of acute myeloid leukemia patients with KMT2A rearrangement

Yi Xu(Loma Linda University), Jiang F. Zhong(University of Southern California), Kevin R. Kelly(Keck Hospital of USC), Jane Xu(Loma Linda University), Saied Mirshahidi(Loma Linda University), Fengzhu Sun(QB3), Kaijin Wu(University of Southern California), Shengwen Calvin Li(Marine Biology Institute of Shandong Province), Xi Zhang(Army Medical University), Julian Olea(University of Southern California), Qin Wen(Army Medical University), Jeffrey Xiao(Loma Linda University), Ruihao Huang(Army Medical University), Hisham Abdel‐Azim(University of Southern California), Cristina Maria Ghiuzeli(University of Washington), Durga Cherukuri(Loma Linda University), Huynh Cao(Loma Linda University), Xiaoqi Wang(Army Medical University), Qian Liu(Southeast University), Yan Liu(Carrier (United States)), Xuelian Chen(University of Southern California), David J. Baylink(Loma Linda University), Esther G Chong(Loma Linda University), Dadrastoussi Homa(University of Southern California), Mark E. Reeves(Loma Linda University)
Drug Resistance Updates
January 2, 2025
Cited by 3


Related Papers